Colfax Corporation plans to split its fabrication technology and specialty medical technology businesses into two independent publicly traded companies by the first quarter of 2022.
“Our intention is to set up both companies with effective capital structures that are aligned with their different strategies,” Colfax CEO Matthew Trerotola said during a 4 March conference call announcing the planned split
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?